Proposed Data Collection Submitted for Public Comment and Recommendations, 3546-3547 [2022-01263]
Download as PDF
<![CDATA[
3546
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
NCHS seeks approval to collect data
for the residential care community
(RCC) and adult day services center
(ADSC) survey components of the 6th
National Post-Acute and Long-Term
Care Study or NPALS (formerly known
as the National Study of Long-Term
Care Providers or NSLTCP). A two-year
clearance is requested.
The NPALS is designed to; (1)
broaden NCHS’ ongoing coverage of
paid, regulated long-term care (LTC)
providers; (2) merge with existing
administrative data on LTC providers
and service users (i.e., Centers for
Medicare and Medicaid Services (CMS)
data on inpatient rehabilitation facilities
and patients, long-term care hospitals
and patients, nursing homes and
residents, home health agencies and
patients, and hospices and patients); (3)
update data more frequently on LTC
providers and service users for which
nationally representative administrative
data do not exist; and (4) enable
comparisons across LTC sectors and
monitor supply and use of these sectors
over time.
Community Living, and the Agency for
Healthcare Research and Quality;
associations, such as LeadingAge,
National Center for Assisted Living,
American Seniors Housing Association,
Argentum, and National Adult Day
Services Association; universities;
foundations; and other private sector
organizations such as the Alzheimer’s
Association, the AARP Public Policy
Institute, and the National Academies of
Sciences, Engineering, and Medicine.
Expected burden from data collection
for eligible cases is 60 minutes per
respondent; 30 minutes for a provider
questionnaire and 30 minutes for a
services user questionnaire. Fifty
respondents will have an additional 30
minutes of expected burden for data
collection about EHR data elements. We
calculated the burden based on a 100%
response rate. Two-year clearance is
requested to cover the collection of data.
The burden for the collection is shown
in the Table below. There is no cost to
respondents other than their time to
participate.
Data will be collected from two types
of LTC providers in the 50 states and the
District of Columbia: 2,090 RCCs and
1,650 ADSCs. Data were collected in
2012, 2014, 2016, 2018, and 2020. The
data to be collected in 2022 include the
basic characteristics, services, staffing,
and practices of RCCs and ADSCs, and
demographics, selected health
conditions and health care utilization,
physical functioning, and cognitive
functioning of RCC residents and ADSC
participants. The 2022 NPALS will
include provider and services user
questionnaires. Directors of 25 RCCs
and 25 ADSCs that have adopted an
EHR platform will complete an
additional questionnaire to identify and
confirm the data elements, any local
customization, and export and
transmission capabilities.
Expected users of data from this
collection effort include, but are not
limited to; CDC, other Department of
Health and Human Services (DHHS)
agencies, such as the Office of the
Assistant Secretary for Planning and
Evaluation, the Administration for
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Avg. burden
per response
(in hours)
Total burden
(in hours)
Form name
RCC Director/Designated Staff Member.
ADSC Director/Designated Staff
Member.
RCC Director/Designated Staff Member.
ADSC Director/Designated Staff
Member.
RCC/ADSC Director/Designated
Staff Member.
RCC Provider Questionnaire ...........
1,045
1
30/60
523
ADSC Provider Questionnaire .........
825
1
30/60
413
RCC Services User Questionnaire ..
1,045
1
30/60
523
ADSC Services User Questionnaire
825
1
30/60
413
EHRs Data Element Questionnaire
25
1
30/60
13
Total ...........................................
...........................................................
........................
........................
........................
1,885
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–01264 Filed 1–21–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22BU; Docket No. CDC–2022–
0006]
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
SUMMARY:
VerDate Sep<11>2014
18:11 Jan 21, 2022
Jkt 256001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Year 7 (2022) Customer Service
Satisfaction Survey for the CDC
Antibiotic Resistance (AR) Isolate Bank.
The proposed information collection
project aims to collect customer service
satisfaction data from AR Isolate Bank
users and will be used to make
improvements to the tool for future
years.
DATES: CDC must receive written
comments on or before March 25, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0006 by any of the following methods:
E:\FR\FM\24JAN1.SGM
24JAN1
3547
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
FOR FURTHER INFORMATION CONTACT:
Background and Brief Description
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
The CDC AR Isolate Bank Customer
Satisfaction Survey will capture
feedback regarding ease of use, product
quality, and expectations for future
panels from AR Isolate Bank customers.
This survey comes six years after the AR
Isolate Bank launched. Since the first
satisfaction survey, the Bank’s customer
base has more than tripled and
represents an even more diverse set of
users. Results may inform additional
new features and/or isolates to meet
these news users’ needs and may also
provide insight for success stories.
Results from the Year 7 survey will be
compared to the previous year’s results
to better determine how each sector is
utilizing CDC’s isolates, assess how well
the customer needs have been met, and
establish areas for future improvement.
Survey results from previous years have
informed upgrades to the Bank’s web
interface and have aided in streamlining
the ordering process. Feedback will be
used as CDC works to continually
improve the Bank’s web interface and
customer engagement process.
Respondents will be those who have
received orders from the AR Isolate
Bank, and represent laboratorians and
researchers at academic research
institutions, device and drug
manufacturers, hospitals and clinics,
state and local health departments, and
other U.S. federal agencies. CDC
requests OMB approval for an estimated
117 burden hours annually. There are
no costs to respondents other than their
time to participate.
Proposed Project
Year 7 (2022) Customer Satisfaction
Survey for the CDC Antibiotic Resistant
Isolate Bank—New—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
CDC’s AR Isolate Bank customers.
Total ..................................
Number of
respondents
Form name
Number of
responses per
respondent
700
1
10/60
117
....................................................................................................
........................
........................
........................
117
[FR Doc. 2022–01263 Filed 1–21–22; 8:45 am]
BILLING CODE 4163–18–P
jspears on DSK121TN23PROD with NOTICES1
Total burden
(in hours)
Year 7 (2022) Customer Service Satisfaction Survey for the
CDC Antibiotic Resistance (AR) Isolate Bank.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Average
burden per
response
(in hours)
18:11 Jan 21, 2022
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 9990
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3546-3547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22BU; Docket No. CDC-2022-0006]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Year 7 (2022) Customer Service
Satisfaction Survey for the CDC Antibiotic Resistance (AR) Isolate
Bank. The proposed information collection project aims to collect
customer service satisfaction data from AR Isolate Bank users and will
be used to make improvements to the tool for future years.
DATES: CDC must receive written comments on or before March 25, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0006 by any of the following methods:
[[Page 3547]]
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Year 7 (2022) Customer Satisfaction Survey for the CDC Antibiotic
Resistant Isolate Bank--New--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC AR Isolate Bank Customer Satisfaction Survey will capture
feedback regarding ease of use, product quality, and expectations for
future panels from AR Isolate Bank customers. This survey comes six
years after the AR Isolate Bank launched. Since the first satisfaction
survey, the Bank's customer base has more than tripled and represents
an even more diverse set of users. Results may inform additional new
features and/or isolates to meet these news users' needs and may also
provide insight for success stories. Results from the Year 7 survey
will be compared to the previous year's results to better determine how
each sector is utilizing CDC's isolates, assess how well the customer
needs have been met, and establish areas for future improvement. Survey
results from previous years have informed upgrades to the Bank's web
interface and have aided in streamlining the ordering process. Feedback
will be used as CDC works to continually improve the Bank's web
interface and customer engagement process.
Respondents will be those who have received orders from the AR
Isolate Bank, and represent laboratorians and researchers at academic
research institutions, device and drug manufacturers, hospitals and
clinics, state and local health departments, and other U.S. federal
agencies. CDC requests OMB approval for an estimated 117 burden hours
annually. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
CDC's AR Isolate Bank customers................ Year 7 (2022) Customer Service 700 1 10/60 117
Satisfaction Survey for the CDC
Antibiotic Resistance (AR) Isolate
Bank.
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 117
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01263 Filed 1-21-22; 8:45 am]
BILLING CODE 4163-18-P
